• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / ETFs

Healthy Gains Continue but Momentum Is Looking Weak

The big question is how much more can this market run on the China news.
By JAMES "REV SHARK" DEPORRE
May 22, 2018 | 07:50 AM EDT
Stocks quotes in this article: ZTCOY, IWM, QQQ, BA, CAT

Further positive develops in the China trade war, a weaker dollar and a slowing in bond yields are giving the indices a further boost this morning.

China plans to cut import duties on cars, the US plans to lift a ban on sales by China technology giant ZTE (ZTCOY) and agricultural tariffs on US farm products are being removed. The threat of a disruptive trade 'war' has been removed and the bears have, once again, been robbed of an obvious negative catalyst.

While the indices managed good sized gains and are adding to them this morning, there hasn't been an explosion of buying and strong momentum. The indices made little, if any, progress intraday after the gap-up open and finding stocks that ended the day at their highs was difficult.

One of the missing elements of the rally was strength in the 'right' leadership stock. Oil-related names dominated the list of new 12-month highs and the Russell 2000 ETF (IWM) managed its fourth-straight new all-time high but the Nasdaq 100 (QQQ)  - home of the FAANG names - lagged with a gain of 0.56% and a poor close. There was not a major rotation into the big cap technology names that looked likely after the recent small-cap outperformance.

This mixed action is partially a function of a rotation. Biotechnology has helped to drive smaller cap names lately but that group lagged and money flowed into a couple of big DJIA names such as Boeing (BA) and Caterpillar (CAT) .

In recent years the market has not needed a steady flow of positive catalysts to keep on running. It was enough that there not be any major negatives. In many situations the negatives turned into positives as they allowed for very aggressive dip buying.

Market conditions have shifted over the past few months as there has been much more hesitancy to ignore new flow and to find positives when there hasn't been one. The response to earnings this past quarter was the best illustration of how good news isn't producing the sort of momentum it had previously.

The big question is how much more can this market run on the China news. Yesterday I discussed how it is not a good move to rush to fade this sort of strength but that doesn't mean that we will see the sort of V-shaped action we have previously.

The technical action is good but it lacks the strong momentum that creates a 'fear of missing out' dynamic. There isn't a sense that the market is going to run away to the upside and we better pile in or we will miss the train. The longer the indices stay positive, the more worry there will be about underperformance but right now this is not a very impressive rally and if we have a poor close it is going to trigger some negative thinking.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, James DePorre had no position in the securities mentioned.

TAGS: Investing | U.S. Equity | ETFs | Funds | China | Markets | Politics | Stocks

More from ETFs

A Few Thoughts on What to Do With ARKK and QQQ

Bob Byrne
Jul 7, 2022 8:30 AM EDT

The latter shows a bit of relative strength, while the former looks to break above resistance.

This ETF Surged While Everyone Else Struggled. How Did It Do It?

Mark Abssy
Jul 6, 2022 11:30 AM EDT

The AGFiQ U.S. Market Neutral Anti-Beta Fund managed to return 18.50% over the past quarter -- and, no, it's not an inverse or levered inverse fund.

The Market Narrative Shifted on Tuesday, So Here's How to Shift With It

Bob Byrne
Jul 6, 2022 8:30 AM EDT

It officially changed from concern over inflation and interest rates to fear of recession, which is causing a change in where traders position themselves.

An Encouraging Development in a 'Terrible' Stock Market

James "Rev Shark" DePorre
Jul 5, 2022 11:20 AM EDT

There's a bright spot, but it needs to be sustained.

Want a Break from Chip Stock Ugliness? Check Out This Biotech ETF and Stock

Bob Byrne
Jul 5, 2022 8:30 AM EDT

The SPDR S&P Biotech ETF is one of the better-looking charts on this trader's screen, as is an individual biotech name.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:41 AM EDT STEPHEN GUILFOYLE

    Reweighting Portfolio Positions Through 5 Trades

    Check out what we're doing in the TheStreet's Stoc...
  • 12:01 PM EDT PAUL PRICE

    A Recent Director Buy in Children's Place (PLCE)

    Four of the most recent insider trades in Children...
  • 07:34 AM EDT PAUL PRICE

    A $525,000 Vote of Confidence on Macerich (MAC)

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login